News Sixty seconds on . . . solanezumab BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6389 (Published 29 November 2016) Cite this as: BMJ 2016;355:i6389 Article Related content Metrics Responses Peer review Related articles Views & Reviews Margaret McCartney: The “breakthrough” drug that’s not been shown to help in Alzheimer’s disease Published: 24 July 2015; BMJ 351 doi:10.1136/bmj.h4064 News Hopes rise for new Alzheimer’s drug after secondary analysis Published: 24 July 2015; BMJ 351 doi:10.1136/bmj.h4048 News Promise of new Alzheimer’s drug is dashed after lack of evidence Published: 24 November 2016; BMJ 355 doi:10.1136/bmj.i6362 Analysis Challenges associated with the development of “trial ready cohorts” for dementia prevention trials Published: 07 January 2025; BMJ 388 doi:10.1136/bmj-2024-080275 See more Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis BMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188 NHS to fund large trial of pre-exposure prophylaxis for HIV prevention BMJ December 05, 2016, 355 i6537; DOI: https://doi.org/10.1136/bmj.i6537 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis BMJ December 01, 2016, 355 i6112; DOI: https://doi.org/10.1136/bmj.i6112 Fertility authority must provide evidence for tests and treatments, say researchers BMJ November 28, 2016, 355 i6400; DOI: https://doi.org/10.1136/bmj.i6400 Cited by... Challenges associated with the development of "trial ready cohorts" for dementia prevention trialsFulltext PDF
